| 产品描述: | VUBI1 (SOS1 activator 1) is a benzimidazole derivative and SOS1 activator with a Kd of 44 nM. VUBI1 can significantly activate RAS-GTP and regulate the phosphorylation of ERK. VUBI1 also can serve as a target ligand for synthesizing PROTACs, such as PROTAC SOS1 degrader-1 , to induce SOS1 degradation. VUBI1 can be used in the study of cancer. |
| 体内研究: |
VUBI1 (Compound 64) (0.3-30 µM; 10 min) 在 HeLa 细胞中可增加 RAS-GTP 水平,并双相调节 ERK1/2 磷酸化 (低浓度时诱导峰值,高浓度时抑制)。 |
| 参考文献: |
1. Timothy R Hodges, et al. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. J Med Chem. 2018 Oct 11;61(19):8875-8894. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.07 ml |
10.352 ml |
20.703 ml |
| 5 mM |
0.414 ml |
2.07 ml |
4.141 ml |
| 10 mM |
0.207 ml |
1.035 ml |
2.07 ml |
| 50 mM |
0.041 ml |
0.207 ml |
0.414 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |